Aspira women's health announces appointment of celeste fralick, ph.d., to its board of directors

Austin, texas, feb. 28, 2022 (globe newswire) -- aspira women's health inc. (nasdaq: awh), a bioanalytical-based women's health company, today announced the appointment of celeste fralick, ph.d., to its board of directors, effective february 23, 2022.

AWH Ratings Summary

AWH Quant Ranking